| __timestamp | United Therapeutics Corporation | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1162636000 | 21584000 |
| Thursday, January 1, 2015 | 1396725000 | 28006000 |
| Friday, January 1, 2016 | 1526100000 | 39623000 |
| Sunday, January 1, 2017 | 1619600000 | 43758000 |
| Monday, January 1, 2018 | 1429100000 | 58930000 |
| Tuesday, January 1, 2019 | 1331200000 | 83845000 |
| Wednesday, January 1, 2020 | 1375200000 | 76028000 |
| Friday, January 1, 2021 | 1563000000 | 145114000 |
| Saturday, January 1, 2022 | 1789600000 | 194954000 |
| Sunday, January 1, 2023 | 2070000000 | 248148000 |
Unlocking the unknown
In the competitive landscape of biotechnology, United Therapeutics Corporation and Veracyte, Inc. have shown distinct trajectories in their gross profit generation from 2014 to 2023. United Therapeutics, a leader in the field, consistently outperformed Veracyte, with its gross profit growing by approximately 78% over the decade. In 2023, United Therapeutics reached a peak gross profit of $2.07 billion, marking a significant milestone. In contrast, Veracyte, while showing growth, achieved a gross profit of $248 million in the same year, reflecting a tenfold increase since 2014. This stark difference highlights United Therapeutics' robust market position and strategic advancements. As the biotech industry evolves, these figures underscore the importance of innovation and strategic planning in driving financial success. Investors and industry watchers should keep a keen eye on these trends as they reflect broader market dynamics.
Gross Profit Analysis: Comparing Amgen Inc. and Veracyte, Inc.
Bristol-Myers Squibb Company vs United Therapeutics Corporation: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or Veracyte, Inc.
Key Insights on Gross Profit: GSK plc vs United Therapeutics Corporation
Gross Profit Trends Compared: GSK plc vs Veracyte, Inc.
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or United Therapeutics Corporation
Biogen Inc. and United Therapeutics Corporation: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? United Therapeutics Corporation or Genmab A/S
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Veracyte, Inc.
United Therapeutics Corporation vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Veracyte, Inc. vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown